Advertisement
Zentek Ltd.

Zentek Ltd. Fundamental Analysis

ZTEKNASDAQ
HealthcareMedical - Instruments & Supplies
$0.46
$0.03(6.72%)
U.S. Market is Open · 12:23
Advertisement

Zentek Ltd. Fundamental Analysis

Zentek Ltd. (ZTEK) shows weak financial fundamentals with a PE ratio of -8.59, profit margin of -8.57%, and ROE of -61.26%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.15

Areas of Concern

ROE-61.26%
Operating Margin-9.28%
Cash Position3.53%
Current Ratio1.00
We analyze ZTEK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -850.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-850.8/100

We analyze ZTEK's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZTEK struggles to generate sufficient returns from assets.

ROA > 10%
-46.51%

Valuation Score

Excellent

ZTEK trades at attractive valuation levels.

PE < 25
-8.59
PEG Ratio < 2
-0.15

Growth Score

Weak

ZTEK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ZTEK shows balanced financial health with some risks.

Debt/Equity < 1
0.16
Current Ratio > 1
1.00

Profitability Score

Weak

ZTEK struggles to sustain strong margins.

ROE > 15%
-6126.01%
Net Margin ≥ 15%
-8.57%
Positive Free Cash Flow
No

Key Financial Metrics

Is ZTEK Expensive or Cheap?

P/E Ratio

ZTEK trades at -8.59 times earnings. This suggests potential undervaluation.

-8.59

PEG Ratio

When adjusting for growth, ZTEK's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values Zentek Ltd. at 5.63 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.63

EV/EBITDA

Enterprise value stands at -8.88 times EBITDA. This is generally considered low.

-8.88

How Well Does ZTEK Make Money?

Net Profit Margin

For every $100 in sales, Zentek Ltd. keeps $-8.57 as profit after all expenses.

-8.57%

Operating Margin

Core operations generate -9.28 in profit for every $100 in revenue, before interest and taxes.

-9.28%

ROE

Management delivers $-61.26 in profit for every $100 of shareholder equity.

-61.26%

ROA

Zentek Ltd. generates $-46.51 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.51%

Following the Money - Real Cash Generation

Operating Cash Flow

Zentek Ltd. generates limited operating cash flow of $-5.66M, signaling weaker underlying cash strength.

$-5.66M

Free Cash Flow

Zentek Ltd. generates weak or negative free cash flow of $-6.04M, restricting financial flexibility.

$-6.04M

FCF Per Share

Each share generates $-0.06 in free cash annually.

$-0.06

FCF Yield

ZTEK converts -8.58% of its market value into free cash.

-8.58%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.63

vs 25 benchmark

P/S Ratio

Price to sales ratio

74.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-0.47

vs 25 benchmark

ROCE

Return on capital employed

-0.62

vs 25 benchmark

How ZTEK Stacks Against Its Sector Peers

MetricZTEK ValueSector AveragePerformance
P/E Ratio-8.5934.27 Better (Cheaper)
ROE-61.26%377.00% Weak
Net Margin-856.93%-42945.00% (disorted) Weak
Debt/Equity0.160.78 Strong (Low Leverage)
Current Ratio1.005.54 Weak Liquidity
ROA-46.51%-162.00% (disorted) Weak

ZTEK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Zentek Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ